BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright ©The Author(s) 2026.
World J Diabetes. Jan 15, 2026; 17(1): 111165
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.111165
Table 1 Comparison of clinical data between diabetic osteoporosis and type 2 diabetes patients, mean ± SD
Group
n
Age (years)
BMI (kg/m2)
Fasting C-peptide (ng/mL)
FBG (mmol/L)
HbA1c (%)
MicroRNA335-3p
PTGS2 (ng/mL)
DM3256.63 ± 8.4224.36 ± 1.912.29 ± 1.219.26 ± 1.789.19 ± 1.132.86 (2.25, 3.36)10.52 (8.25, 12.91)
DOP3065.40 ± 8.6021.12 ± 1.521.29 ± 0.5910.75 ± 2.2310.28 ± 2.281.56 (1.03, 2.52)15.03 (12.66, 16.77)
Z/t4.06a-7.44a-4.10a2.88a2.62a-5.072a-5.163a
Table 2 Factors affecting diabetic osteoporosis in binary logistic regression analysis
Factors
β
Standard Error
Wald χ2
OR (95%CI)
MicroRNA-335-3p-2.6441.2745.6950.071 (0.006-0.863)a
BMI-0.5110.2563.9830.600 (0.363-0.991)a
Fasting C-peptide-1.5530.7704.0640.212 (0.047-0.958)a